"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Infiltrating Duct and Lobular Carcinoma In Situ|Invasive Lobular Breast Carcinoma|Inflammatory Breast Carcinoma
Interventions: DRUG: Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab|DRUG: Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab|DRUG: Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab
Sponsor: Auxilio Mutuo Cancer Center